EUVIMEDEUVIMED entdecken
FallberichtOpen Access · CC BY 4.0

Case Report: Spindle cell metaplastic breast carcinoma

Yanze Liu, Xiaoyu Sun, Jiaqi Liu

Frontiers in Oncology · 19.08.2026 · 16

DOI: 10.3389/fonc.2026.1920800 ↗

Kurz gefasst

Fallbericht in der Zeitschrift Frontiers in Oncology, online erschienen am 19.08.2026. Verfasst von Yanze Liu und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Breast and Thyroid Surgery, Zibo Central Hospital, Zibo, Shandong, China. Die Arbeit nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Spindle cell metaplastic breast carcinoma (SpCC) is an uncommon subtype of metaplastic breast carcinoma. It often shows a triple-negative phenotype and can closely mimic malignant phyllodes tumor, primary breast sarcoma, and other spindle-cell lesions of the breast. Case presentation A 56-year-old woman presented with a 5.4-cm right breast mass. Core needle biopsy showed high-grade spindle cell carcinoma. The tumor expressed CKAE1/AE3, CK8/18, EMA, vimentin, TRPS-1, and partial GATA3, and was negative for ER, PR, HER2, p40, p63, CK5/6, S-100, CD34, and ERG; the Ki-67 index was 85%. BRCA1/2 testing showed no detectable mutation. After six cycles of albumin-bound paclitaxel plus carboplatin, ultrasound and MRI showed marked tumor regression. Modified radical mastectomy revealed residual degenerated malignant cells and ductal carcinoma in situ , with Miller-Payne grade 4 response and no metastasis in 17 axillary lymph nodes. The patient received postoperative radiotherapy and low-dose capecitabine. At the latest follow-up on June 25, 2026, there was no evidence of locoregional recurrence or distant metastasis.

Conclusion

This case supports a diagnosis-centered approach to SpCC, using spindle-cell morphology together with epithelial and breast-lineage markers and exclusion of key mimics. A platinum-taxane neoadjuvant regimen achieved a major pathological response in this patient, but evidence for SpCC remains limited and treatment should be individualized.

Schlagwörter

Stichwörter der Autor:innen

Miller-Payne gradecarboplatincase reportmetaplastic breast carcinomaneoadjuvant chemotherapyspindle cell carcinomatriple-negative breast cancer

Autor:innen und Institutionen

  • Department of Breast and Thyroid Surgery, Zibo Central Hospital, Zibo, Shandong, China.
  • Department of Pathology, Zibo Central Hospital, Zibo, Shandong, China.

Zitieren

APA

Liu, Y., Sun, X., & Liu, J. (2026). Case Report: Spindle cell metaplastic breast carcinoma. Frontiers in Oncology, 16. https://doi.org/10.3389/fonc.2026.1920800

Vancouver

Liu Y, Sun X, Liu J. Case Report: Spindle cell metaplastic breast carcinoma. Frontiers in Oncology. 2026;16. doi:10.3389/fonc.2026.1920800

BibTeX
@article{Liu2026,
  author = {Liu, Yanze and Sun, Xiaoyu and Liu, Jiaqi},
  title = {Case Report: Spindle cell metaplastic breast carcinoma},
  journal = {Frontiers in Oncology},
  year = {2026},
  volume = {16},
  doi = {10.3389/fonc.2026.1920800}
}
Kostenlos starten →